NCT05629377View on ClinicalTrials.gov

Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH)

RecruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

January 17, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Hypothalamic Amenorrhea
Trial Locations (1)

32224

RECRUITING

Mayo Clinic Florida, Jacksonville

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Mayo Clinic

OTHER

NCT05629377 - Hypothalamic Amenorrhea as a Fertility Status Marker for Cardiovascular Health (ARCH) | Biotech Hunter | Biotech Hunter